Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Arzoxifene

Generic Name: Arzoxifene

Drug Type: Small Molecule

Chemical Formula: C_₂₈H_₂₉NO_₄S

CAS Number: 182133-25-1

Unique Ingredient Identifier: E569WG6E60

Overview

No overview information available.

Background

No background information available.

Indication

Investigated for use/treatment in breast cancer, osteoporosis, and endometrial cancer.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study of Arzoxifene to Treat Korean Women With Osteoporosis

Phase 2

Completed

Posted: 2008/10/07

Sponsor:Eli Lilly and Compan...

ID:NCT00767299

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

Phase 3

Completed

Posted: 2006/10/03

Sponsor:Eli Lilly and Compan...

ID:NCT00383422

Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

Phase 2

Completed

Posted: 2005/11/15

Sponsor:The Cleveland Clinic

ID:NCT00253539

A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

Phase 4

Completed

Posted: 2005/09/19

Sponsor:Eli Lilly and Compan...

ID:NCT00190697

Hormone Therapy in Treating Women With Breast Cancer

Phase 2

Completed

Posted: 2004/09/13

Sponsor:Memorial Sloan Kette...

ID:NCT00003428

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy